Article Information
History
- July 9, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pulleri Kandi Harsha1,
- Chitra Pattabiraman1,
- Anson Kunjumon George1,
- Madhusudhan J1,
- Saumitra Mardikar1,
- Mudasir Nazaar1,
- Srivathsan Adimoolam1,
- Divya Priya A1,
- Jayee Pitale1,
- Mahesh Nagarajan1,
- Srikant Sridharan1,
- Yasodha Kannan1,
- Anand Janakiraman1,
- Vamsi Veeramachaneni1,
- Ramesh Hariharan1,2,
- Vishal US Rao3,5,
- Mohammed Shariff7,
- Thrilok Chandra4,
- K. Sudhakar6,
- Randeep Dev5,
- Ravi Vasanthapuram5 and
- Vijay Chandru1,2,5,*
- 1Strand Life Sciences Private Limited, Bengaluru, India
- 2Indian Institute of Science, Bengaluru, India
- 3Centre for Academic Research, Health Care Global Cancer Hospital, Bengaluru, India
- 4Bruhat Bengaluru Mahanagara Palike (BBMP), Bengaluru, India
- 5Genomic Surveillance Committee, Karnataka, Health & Family Welfare Services, Karnataka, India
- 6Minister for Medical Education & Health & Family Welfare, Government of Karnataka, India
- 7Department of health and family welfare services, Karnataka
- ↵*Corresponding author: Vijay Chandru, vijaychandru{at}iisc.ac.in
Posted July 09, 2022.
The role of SARS-CoV-2 genomic surveillance and innovative analytical platforms for informing public health preparedness in Bengaluru, India
